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ABSTRACT 
UV radiation (UV) is considered as a complete carcinogen as it is both a mutagen and a non-specific damaging agent. It is the most important risk 
factor for skin cancer and many other skin disorders like Hyperpigmentation. There is a need of long-term topical skin care treatments (both 
cosmetic and cosmeceutical) to address problems associated with hyperpigmentation. Synthetic depigmenting agents, such as hydroquinone, 
mequinol, although highly effective, can raise several safety concerns (for example, ochronosis, cataract, impaired wound healing, desquamation, 
and other local or systemic side effects) with long-term exposure. The benefits of phytochemicals and natural extracts offer opportunities to 
develop new formulations to treat pigmentation problems. Cosmeceuticals are topical cosmetic-pharmaceutical preparations containing active 
ingredients which improve the appearance of skin. Among cosmeceuticals, the phytochemicals have been known to have a multitude of cellular 
actions for various dermatological diseases. Plant-derived compounds and their effectiveness in the treatment of hyperpigmentation disorders 
(Melasma) are discussed.  
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1. INTRODUCTION 
Human skin is the superficial layer which is exposed to 
various environmental stimuli such as humidity, dust, 
microbes and UV radiation. Due to day-to-day change in 
environmental conditions, these UV rays are affecting 
epidermis as well as dermis of the skin. UV radiation can be 
classified into UV-A, -B and -C. UV-A has the least energetic 
photons with the longest wavelength, lying between 315-
400nm, UV-C has the highest energetic photons with the 
shortest wavelength lying between 100-280nm, while UV-B 
lies in between1. On the basis of their exposure, UV affects 
skin physiology, causing acute or delayed pigmentation2. 
The cosmetic and pharmaceutical industries aim to achieve 
the needed therapy for treatment of skin pigmentation. 
Relating to cosmetic and aesthetic role, skin lightening 
formulations help to provide action against 
hyperpigmentation, melasma, post inflammatory 
hyperpigmentation, photo ageing, skin cancer and 
phototoxicity3. Skin-lightening agents, derived from herbal 
sources are considered as safe and efficient ingredients, 
certified for use in cosmetics4. 
Hyperpigmentation is a skin disorder that occurs due to an 
increase in cutaneous melanin deposition either through rise 
in melanin synthesis or melanocytes, the specialized cells 
producing melanin5. Based on the location of deposition of 
melanin granules, hyper pigmentation can be divided into 
epidermal and dermal hyper pigmentation6.  
Epidermal hyper pigmentation occurs due to melanin 
pigmentation and is visualized as brownish blue, while, 
dermal pigmentation k/a ‘ceruloderma’ or ‘blue hyper 
pigmentation’ occurs due to melanin or non-melanin 
pigments7. The melanocytes are located at basal layer which 
on increased activity results in hyperpigmentation. However, 
in some cases melanin formation may be transferred to the 
dermis. In these instances, a rise in activity or number of 
melanocytes leads to dermal hyper pigmentation8. 
2. MECHANISM 
The damage at cellular level initiates transcription of the 
pro-opiomelanocortin (POMC) gene, leading to production 
and secretion of melanocyte stimulating hormone (α-MSH). 
In the basal epidermis, binding of α-MSH with melanocortin 
1 receptor (MC1R) on melanocyte, produces cAMP through 
interaction between MC1R and adenylyl cyclase. This results 
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in activation of cAMP responsive binding element (CREB), 
microphthalmia transcription factors (Mitf) and protein 
kinase A. CREB and Mitf accelerate melanin production by 
elevating tyrosinase level. Rise in tyrosinase level produces 
melanin, leading to hyperpigmentation of skin 1,9,10 (Fig. 1). 
 
 
Figure 1: Mechanism of hyperpigmentation 
 
3. APPROACHES FOR TREATMENT OF 
HYPERPIGMENTATION BY PHYTOCHEMICALS 
3.1Tyrosinase inhibition and related enzyme expression 
The expression of tyrosinase and other melanogenic 
enzymes is modified in the initial stage i.e the transcriptional 
level11. Research and formulation of novel skin lightening 
agents from natural sources needs various phytoconstituents 
to be analyzed, that inhibit formation of tyrosinase, 
tyrosinase related protein-1 (TRP1) and tyrosinase related 
protein-2 (TRP-2)12. 
Cho et al. studied and demonstrated that isoimperatorin and 
imperatorin obtained from ethanolic extract of Angelica 
daburica showed inhibition of tyrosinase synthesis in Bl6 
melanoma cells by reducing the level of tyrosinase m-RNA, 
leading to skin whitening 13. 
3.2 Inhibition of tyrosinase activity 
Majority of the herbal depigmenting compounds act by 
interfering in the melanin synthesis pathways by inhibiting 
tyrosinase activity12. These types of tyrosinase inhibitors are 
prevalent and herbal extracts serve as good source of 
naturally occurring tyrosinase inhibitors which are used as 
traditional therapies for pigmentation disorders14,15. 
Based on the in vitro studies, Green tea is known to be a 
competitive tyrosinase inhibitor. The major catechin 
constituents: epicatechin gallate, epigallocatechin gallate and 
gallocatechin gallate are responsible for this effect16. 
As studied by Picardo and Carrera, aloesin from Aloe vera 
acts as a non-competitive inhibitor of tyrosinase, affecting 
the tyrosinase complex, resulting in the conversion of DOPA 
into melanin. 17.  
Tan et al. reported that aloin isolated from Aloe vera leaf 
extract serves as a natural skin lightening agent which binds 
to the enzyme- substrate complex in addition to tyrosinase 
enzyme, thus inactivating the enzyme that results in 
lightening of skin18.    
Glycyrrhiza glabra is a commonly used compound in the skin 
lightening industry, which inhibits tyrosinase and reduces 
the formation of pigment in melanocyte cells. Studies of 
Nerya et al. and Fu et al revealed that glabridin and 
isoliquiritigenin, the main constituents of the licorice extract 
inhibit tyrosinase activity in B16 murine melanoma cells19,20.  
Research showed that skin lightening potential of glabridin is 
greater than that of hydroquinone, the artificial 
depigmentation agent widely used20,21. 
Hesperidin, a bioflavonoid also exhibits dose-dependent 
antityrosinase activity in B16 melanoma cells that results in 
inhibition of melanin synthesis without any cytotoxicity22. 
3.3 Inhibition of Melanin dispersion  
Several studies have analyzed the regulatory factors of the 
melanosome movement and the interaction between 
keratinocytes and melanocytes during the transfer 
process23,24.  
Hence, various compounds are known to have an effect on 
the melanin transfer from melanocytes to keratinocytes, 
leading to skin lightening and therefore can treat 
hyerpigmentation disorders13. 
Recent studies revealed that Aloe vera extract aids in skin 
lightening through stimulation of adrenergic receptors of 
various subtypes in different melanophore models25.  
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3.4 Melanin degradation control and removal 
Some compounds increase the degradation and removal of 
pigment granules from the skin. They remove excessive 
melanin and are used as cosmetic and therapeutic agents13.  
Studies conducted by Amer and Metwalli, demonstrated that 
liquirtin isolated from Licorice root extracts, exhibited 
potent skin lightening benefits in melasma patients, by 
removing keratinocytes, shortening the cell cycle and 
facilitating rapid pigment loss26.  
4. ROLE OF PHYTOCHEMICALS FOR TREATMENT 
OF HYPERPIGMENTATION 
Phytochemicals and natural products with skin-lightening 
properties are meeting demands of consumers and 
researchers due to their mild, safe, and healthy action than 
synthetic alternatives. Botanicals are extensively being used 
in skin lightening cosmetics and are promising agents with 
great potential for future use, because scope of natural 
treatments is considered efficient for treatment of 
hyperpigmentation. The phytochemicals used to treat 
hyperpigmentation are listed in Fig. 2. Since, hydroquinone 
is one of the standard treatments27, however, a number of 
adverse effects have been reported such as skin irritation, 
cutaneous and contact dermatitis28. Due to adverse drug 
reaction, hydroquinone has been banned in several countries 
including European Union29. Advancement in cosmeceuticals 
and phytochemical industry led to an investigation of natural 
plant extracts. Active plant compounds are found to be 
potent inhibitors of melanin formation than hydroquinone as 
they do not involve any cytotoxicity. The clinical prospects 
and the activity of different phytochemical compounds have 
been listed below28 in Table 1. 
 
 
Figure 2: Classification of depigmenting Phytochemicals 
 
4.1 Aloesin  
Aloesin is a botanical compound obtained from aloe plant. It 
competitively inhibits tyrosinase level from human and 
murine sources. It significantly inhibits 3,4-
dihydroxyphenylalanine (DOPA) oxidase, which further 
inhibit tyrosinase activity30. 
Wang et al., using reconstituted human skin, studied the 
effects of aloesin on melanogenesis and found that aloesin 
had direct inhibitory effects on melanogenesis and exhibited 
dose-dependent reductions in tyrosinase activity and 
melanin content31. 
In a study by Jones et al., aloesin is shown to modulate 
melanogenesis via competitive inhibition of tyrosinase 
enzyme and is considered as an effective alternative for 
treating pigmentation for cosmetic or therapeutic 
applications32. 
4.2 α-bisabolol 
α-bisabolol, the primary constituent of the Matricaria 
chamomilla plant is a monocyclic sesquiterpene alcohol. This 
compound has tremendous application including anti-
inflammatory, antibiotic, analgesic and gastric protection33. 
The anti-inflammatory effect of bisbolol masks 
photoprotection34. Moreover, it was found that α-bisabolol 
also inhibits α-MSH induced melanogenesis by suppressing 
cyclic adenosine monophosphate level35. This is mediated by 
blocking CREB phosphorylation induced by protein kinase A 
(PKA)36. Hence it is considered as an effective inhibitor of 
hyperpigmentation.  
In a double blind, vehicle control study by Lee et al., α-
bisabolol was evaluated for its efficacy on hyper-
pigmentation. The cream containing 0.5% α-bisabolol and 
vehicle control was tested on Korean women of age 32-52 
years for about 2 months. A stronger whitening effect was 
observed with α-bisabolol than control vehicle. As per the in 
vivo studies, alpha-bisabolol was essentially utilized as an 
adjunctive therapy for the treatment of hyper-
pigmentation33. 
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4.3 Arbutin 
Arbutin, a hydroquinone-O-β-D glucopyranoside, from leaves 
of plant named bearberry, obtained from the fruit Aesculus 
californica Nutt, and cranberry. Arbutin acts by inhibiting the 
activity of melanosomal tyrosinase and 5,6- 
dihydroxyindole-2-carboxylic acid (DHICA) at noncytotoxic 
concentrations. Therefore, arbutin inhibited tyrosinase 
activity37,38. 
In a randomized, prospective, open label study by Ertam et 
al., the efficiency of ellagic acid (EA) and arbutin in melasma 
was studied. Women with the ages ranging 26–50 years 
were selected. Fifteen of 20 patients were found to have 
epidermal melasma, while five had a mixed type of melasma. 
Ten patients each were tested with natural EA, synthetic EA 
and arbutin. Reduction in pigmentation was observed by 
using arbutin and natural EA. Arbutin efficiency is proven for 
treating melasma and it was concluded that natural EA had 
same efficiency as that of arbutin39. 
4.4 Ellagic acid 
Ellagic acid is a polyphenolic compound obtained from green 
tea, strawberry, cherries, walnut and geranium. It helps in 
providing relief from pigmentation caused by UV radiation.  
In vitro studies proved reduction in melanogenesis by 
inhibition of tyrosinase at cellular level by using EA. The 
inhibition is found to be caused by chelation of copper 
molecules on tyrosinase40,41. 
Shimogaki et al., conducted study on the efficacy of ellagic 
acid on melanogenesis inhibition and performed in vitro and 
in vivo evaluation. Tyrosinase activity in the B16 medium 
melanoma cells was found to recover in a dose-dependent 
manner when copper ions were added to the medium 
containing ellagic acid40.  
Kasai et al analyzed the effects of oral administration of 
ellagic acid- rich pomegranate extract on UV-induced 
pigmentation in the skin. It had a protective effect on slight 
sunburn even at low doses. Hence it can be concluded that 
ellagic acid-rich pomegranate extract proved to be a 
whitening health food41. 
4.5 Liquiritin 
Liquiritin is an active compound of Liquorice extract 
(Glycyrrhiza glabra). Liquiritin generally has no effect on 
tyrosinase but it helps in melanin dispersity and thereby 
causing epidermal removal. Amer and Metwali, 
demonstrated effect of liquiritin cream applied 1g daily for 4 
weeks showing the benefit in melasma42.  
Zubair and Mujtaba, analyzed the effect of topical liquiritin 
application on 90 patients for melasma. A formulation of 2% 
and 4% liquiritin along with 4% hydroquinone was analyzed. 
The study showed that 4% liquiritin showed better result on 
melasma as compared to 2% liquiritin and 4% 
hydroquinone43. 
4.6 Silymarin 
Silymarin, a natural polyphenolic flavonoid is a biologically 
active component with antioxidant properties. Derived from 
the milk thistle plant Silybum marianum, it prevents melanin 
production in a dose-dependent manner without effecting 
cell viability and reduces and suppresses hazardous effects 
of UV44,45. 
Silymarin is also involved in the inhibition of l-DOPA 
oxidation activity of tyrosinase, the rate limiting 
melanogenic enzyme. It was also determined that silymarin 
decreased the expression of tyrosinase protein by western 
blot analysis. Hence it was concluded that silymarin may be 
useful as a natural skin-lightening agent.  
In a double-blind, placebo-controlled study by Altaei, the 
safety and efficacy of topical silymarin cream was assessed at 
two different doses for treatment of 96 melasma patients. 
Both the creams were reported to reduce the Melasma Area 
and Severity Index score to 046. 
4.7 Glabridin 
Glabridin, a pyranoisoflavan is an active ingredient in 
liquorice extract derived from Glycyrrhiza glabra. It exerts an 
anti-inflammatory action and is a potent inhibitor of 
melanogenesis.  
Yokota et al investigated in vitro the inhibitory effects of 
glabridin on melanogenesis and inflammation by using 
cultured B-16 murine melanoma cells and guinea pig skin. 
The depigmentation was studied with a colorimeter and 
number of melanocytes were determined by histochemical 
analysis. It was concluded that glabridin inhibits tyrosinase 
activity but has no effect on DNA synthesis47.  
Chen et al determined the inhibitory kinetics of glabridin on 
tyrosinase along with their binding mechanisms by 
spectroscopic, zebrafish model and molecular docking 
techniques. It was observed that glabridin reversibly inhibits 
tyrosinase in a noncompetitive manner through a multiphase 
kinetic process48. 
4.8 Hesperidin 
Hesperidin is a predominant flavonoid derived from citrus 
fruits. Zhu and colleagues studied and demonstrated 
hesperidin’s potent ability to inhibit melanin synthesis 
without cytotoxicity28,49. This study led to dose-dependent 
inhibition of tyrosinase activity (vs control) of hesperidin in 
melanoma B16 cells and human primary melanocytes50.  
Proteggente found that hesperidin protected against 
oxidative damage of collagen and UVA-induced damage of 
fibroblasts51. Hence, hesperidin has potential skin-lightening 
benefits, along with improved overall skin tone and anti-
yellowing effects. 
Recent studies showed that hesperidin induces 
melanogenesis in murine melanoma cells when added to the 
culture medium, which, if extrapolated to in vivo conditions, 
would lead to hyperpigmentation. 
Furthermore, in a study by Usach et al, it was found that 
hesperidin concentrations of 25 and 50 μM induced melanin 
synthesis and tyrosinase activity in human melanocytes in a 
concentration-dependent manner. Both these results suggest 
that hesperidin increases melanin in human skin52. 
4.9 Procyanidin 
Procyanidin, the main active component of Pinus pinaster 
bark extract is a promising therapeutic compound for 
treatment of pigmentation. It has both anti-inflammatory 
and antioxidant action. The mechanism of action lies in 
inhibition of the proliferation of melanocytes and melanin 
synthesis by tyrosinase in melanocytes53.  
Handog et al conducted a double-blind, placebo-controlled 
prospective using 30 healthy female volunteers who were 
treated with procyanidin for 30 days. Variations in 
pigmentation were recorded using a mexameter. The study 
revealed improvement in level of lightening of melasma in 
the treatment group54.  
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Clark and Sivamani carried out a randomized, double-blind, 
placebo-controlled trial lasting 8 weeks, involving 60 Filipino 
patients with bilateral epidermal melasma, the safety and 
efficacy of procyanidin along with vitamins A, C, and E was 
evaluated. Mexameter measurements showed a significant 
decrease in the degree of pigmentation, suggesting that 
procyanidin combination with vitamins A, C, and E is safe 
and well tolerated, with minimal adverse events35. 
4.10 Green tea 
Green tea extracts, comprising multiple polyphenolic 
antioxidants, of which epigallo-catechin-3-gallate (ECGC) is 
the main constituent55,56.  
Syed et al studied the clinical efficacy, safety, and tolerability 
of 2% analogue of green tea extract (EGCG) in a hydrophilic 
cream for melasma treatment in women. 60 subjects, aged 
18 to 50 years with centrofacial, malar, and mandibular 
types of lesions were selected. Patients were randomized 
according to sequence into two parallel groups. A substantial 
improvement was observed in both the groups. Therefore, 
the cream was observed to highly reduce mean lesion count 
than placebo. In terms of clearing lesions, therapeutic 
success was observed in 60% of the active group and 3% in 
placebo subjects57.   
Elmets evaluated the effect of polyphenols on cutaneous 
photoprotection along with its analysis. Skin of volunteers 
was treated with green tea extract or one of its constituents. 
Thirty minutes later, the treated locations were exposed to a 
2 minimal erythema dose solar simulated radiation. UV-
treated skin was observed clinically for UV-induced 
erythema, histologically for the presence of Langerhans cell 
distributions, or biochemically for UV-induced DNA damage. 
Polyphenolic extracts of green tea were proved to be 
effective chemopreventive agents against adverse effects of 
UV on human health and may thus serve as natural 
alternatives for photoprotection58. 
 
Table 1: Overview of depigmenting action of phytochemicals 
Phytochemical Plant source Mechanism Uses Reference 
Aloesin Aloe vera Inhibition of tyrosinase, 
Decrease DOPA oxidase 
UV radiation 
hyperpigmentation 
Jones et al., 2002 
Choi et al., 2002 
Alpha-bisabolol Chamomile Inhibits alpha MSH-induced 
melanogenesis by 
suppressing cAMP 
UVA and UVB tanned 
skin (with solar 
simulator) 
Lee et al., 2010 
Arbutin California buckeye, 
bearberry, cranberry, and 
blueberry 
Inhibits DHICA polymerase 
and tyrosinase 
Solar lentigines Boissy et al., 
2005 
Ellagic acid Green tea, geranium, 
strawberry, grapes, walnuts 
and cherries 
Decrease melanocyte 
proliferation, Copper 
chelation 
Melasma Ertam et al., 
2008 
Liquiritin Liquorice Dispersion of Melanin, 
epidermal removal 
Melasma Zubair and 
Mujtaba, 2009 
Silymarin Silybum marianum 
(standardized extract) 
Inhibits l-DOPA oxidation 
activity of tyrosinase 
Melasma Atlaei, 2012 
Glabridin Liquorice Tyrosinase inhibition UVB-induced 
pigmentation 
Yokota et al., 
1998 
Hesperidin Citrus fruits Collagen antioxidant, 
tyrosinase inhibition  
Inhibits melanin synthesis 
UV-A induced and 
oxidative damage of 
collagen 
Usach et al., 
2015 
Procyanidin Pinus pinaster Anti-inflammatory and 
antioxidant 
Melasma Handog et al., 
2009 
Green tea Camellia sinensis Antioxidant 
Tyrosinase inhibition 
Melasma Liang et al., 
2014 
 
5. ALTERNATIVES TO PHYTOCHEMICALS 
5.1 Phenolic compounds 
a) Hydroquinone (HQ) 
Hydroquinone is a dihydric phenolic compound with two 
important constituents namely monobenzyl and 
monomethyl ether of hydroquinone. Hydroquinone 
competitively inhibits sulfhydryl groups that act as a 
substrate for tyrosinase, thereby inhibiting melanin 
formation59,60,61. HQ is commonly used in the concentration 
of 2-4%62. Higher concentrations are found to be effective 
but can cause irritation.  
Limitation: Although having advantages, HQ has got so 
many limitations. Chronic adverse effects have been 
reported including exogenous ochronosis, pigmented colloid 
milia, sclera, cataract, nail pigmentation, loss of skin 
elasticity and impaired wound healing63. HQ can even cause 
DNA damage and therefore, international agency for 
research on Cancer has placed hydroquinone as non 
classifiable agent. A proposal was also passed by Food and 
Drug administration (FDA) on banning of skin bleaching 
agent containing hydroquinone64.  
b) Mequinol 
Mequinol (4-hydroxyanisole) is a phenolic compound that 
competitively inhibits tyrosinase without damaging 
melanocytes65. A study conducted by Jarratt, involving 216 
volunteers, analyzed the effect of 2% mequinol and 0.01% 
tretinoin. The solution was effective and well tolerated for 
hyperpigmentation and solar lentigines66. 
Limitation: Mequinol causes erythema, burning, 
desquamation and hypopigmentation. 
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c) N-acetyl-4-S-cysteaminylphenol (NCAP) 
It is a phenolic substrate which inhibits tyrosinase activity. It 
is safer than hydroquinone and shows clinical response after 
2-4 weeks for melasma11. 
5.2 Laser treatments 
Fractional laser therapy, for melasma is the only laser 
treatment approved by US Food and Drug Administration. As 
observed in a study, evaluating the efficacy of lasers in 10 
female subjects, it showed promising results67,68. 
Limitation: Q-switched ruby, Erbium-yttrium-aluminium 
garnet, and Q-switched alexandrite 755-nm lasers, are not 
generally recommended because of ineffectiveness and 
increased risk of adverse events67,69. 
5.3 Chemical peels 
Chemical peels such as alpha hydroxyl acids and beta 
hydroxyl acids have been used for many years in the 
treatment of melasma. A cream containing 10% glycolic acid 
and 2% hydroquinone in combination with glycolic acid peel 
(at 3-weeks interval) showed lightening of melasma and fine 
facial wrinkling70.  
Limitation: Although improvement in melasma was 
observed by using glycolic acid, but adverse effect of a 
painful burn in the glycolic acid peel group was analyzed 
with ensuring post-inflammatory hyperpigmentation for 2 
months in one case. 
6. APPLICATION OF NANOTECHNOLOGY IN 
HYPERPIGMENTATION 
Nanoparticles are small substances which act and react as a 
whole unit having dimension between 1 to 100nm. These are 
widely used in the field of dermatology. Nanoparticles such 
as liposomes, niosomes, dendrimers, solid lipid 
nanoparticles as well as silver and gold nanoparticle are 
gaining attention in this era. Their penetration and prolong 
action make them widely used in field of cosmetics. Solid 
lipid nanoparticles and nanostructured lipid carriers are 
advantageous due to their high stability along with providing 
moisturizing effect71.  
Hydroquinone is well known for its anti-hyperpigmentation 
activity but due to its adverse effect on skin, its application is 
limited.  Since hydroquinone has hydrophilic structure, it 
does not penetrate easily in to the skin. Moreover, it oxidizes 
rapidly. Ghanbarzadeh et al., formulated solid lipid 
nanoparticle of hydroquinone. The optimized hydroquinone 
loaded solid lipid nanoparticles indicated better localization 
of hydroquinone into the skin making it promising drug 
carrier for topical administration of HQ in the treatment of 
hyperpigmentation72.  
In another study, Tokton et al, developed ellagic acid rich 
pomegranate peel extract (EPP) loaded nanostructure lipid 
carrier (NLCs). EPP was formulated using warm 
microemulsion technique having anti tyrosinase value with 
IC50 28.54 ± 1.34 µg/ml. It had high entrapment efficiency 
and better penetrability. This denotes that apart from 
treating hyperpigmentation, nanoparticles are efficacious for 
promoting product stability and fucnctionality73. 
7.  FUTURE PROSPECTS 
Since the global population continues to age, and years of 
sun damage along with influence of fluctuating hormones, 
results in uneven pigmentation. This tends to continuously 
increase worldwide. Today’s consumers are not only looking 
to treat Melasma, but to create a more even skin tone with 
enhanced luminosity.  
Formulation development of anti-hyperpigmentation 
products is a challenging phenomenon.  
Various studies have been performed and nano formulations 
have been developed. However, many phyto components 
exist in which micro and nano formulations have still not 
been explored.  
Development of novel formulations such as SMEDDs, nano, 
micro, artificial intelligence can be further included. 
Additionally, sprays and mists for melasma can be obtained 
so that drug can easily diffuse through the skin.  
The effectiveness of depigmenting formulations can be 
enhanced by incorporating sun screen boosters like titanium 
dioxide (TiO2), kaolin, talc, zinc oxide (ZnO), calcium 
carbonate. Newer chemical compounds, such as 
bemotrizinol, avobenzone, bisoctizole, oxybenzone, and 
octocrylene, are broad-spectrum agents and are effective 
against a broad range of solar spectrum. 
In addition moisturizers or “antiaging” ingredients can 
support skin health thereby reducing the appearance of 
wrinkles. Hence, by incorporating these compounds, an 
effective depigmenting action along with a photoprotection 
effect can be obtained. 
8. CONCLUSION 
Treatment of pigmentation poses a challenge to skin care 
experts and a broader field is necessary to improve 
treatments for hyperpigmentation. A huge dimension of safe 
and effective de-pigmenting botanicals exists as promising 
alternatives to current drugs, such as, hydroquinone. 
Phytochemical extracts represent a large area for skin-
lightening formulations. Further studies that integrate 
botanicals with standard treatments are desirable for the 
treatment of Melasma. 
Nanotechnology has primarily gained importance in 
dermatology, in relation to manufactured products, 
especially in the cosmetics industry, leading to innovation in 
the treatment of inflammatory and immunomediated 
dermatoses through more effective medications involving 
less side effects. 
In vitro studies show that these agents may prove to be an 
additional potential for protective cosmeceutical use, 
through antioxidant effect and protection of 
macromolecules, such as collagen from UV irradiation. So, 
natural plant extracts may offer the potential to significantly 
expand the choices for skin-lightening formulations and 
address the need for better ways to treat Melasma. 
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